Victorian Premier, The Hon Daniel Andrews, has announced the signing of a letter of intent to collaborate between Melbourne Genomics and the Broad Institute of Harvard University and MIT.
The Eli and Edythe L. Broad Institute aims to transform medicine through the use of systematic approaches in the biological sciences to dramatically accelerate the understanding and treatment of disease, and provides a highly collaborative and cross-disciplinary model for a research institute. The Broad's key areas of focus include: assembling a complete picture of the molecular components of life; defining the biological circuits that underlie cellular responses; uncovering the molecular basis of major inherited diseases; unearthing all the mutations that underlie different cancer types; and transforming the process of therapeutic discovery and development.
Melbourne Genomics and the Broad share the objective of greater incorporation of genomics into healthcare, so conversation and sharing between the two has naturally developed. The letter of intent gives a formal basis to this collaboration, providing an ongoing platform for discussions and the exchange of ideas and skills, across areas of mutual interest.
"We are very excited by our relationship with the Broad Institute," said Melbourne Genomics’ Executive Director, Associate Professor Clara Gaff. "The letter commits both parties to strengthening our relationship over time, and to sharing best practice and expertise."
[Image: The Broad Institute of Harvard University and MIT]